APEIRON INVESTMENT GROUP LTD. enters SENSEI BIOTHERAPEUTICS, INC. with 3.44M shares across direct and indirect positions
This filing by APEIRON INVESTMENT GROUP LTD. establishes the baseline for all future Form 4 insider transaction reports at SENSEI BIOTHERAPEUTICS, INC..
Indirect
Filed: 7/20/2022ACC: 0000899243-22-026393
10% Owner
Since Jul 2022
3.44M
Baseline shares
0.00
Direct ownership
0 positions
0.00
Derivative underlying
0 instruments
2
Security positions
3.44M indirect
Non-Derivative Holdings2
Common Stock
IndirectShares owned955.74K
Common Stock
IndirectShares owned2.48M
Total
3.44M indirect3.44M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 955.74K | Indirect |
| Common Stock | 2.48M | Indirect |
| Total | 3.44M | 3.44M indirect |
Derivative Holdings0
No derivative holdings reported